For instance, mice that became susceptible to virus infection through a previous intranasal treatment with an ACE2-expressing adenoviral vector controlled the viral spread by virtue of the activation of virus-specific CD4+ and CD8+ T cells in the absence of neutralizing antibodies [38]. The gene discussed is CD8A; the disease is viral infectious disease.